Ajooni Biotech Complete Financial Statements

In FYNone, Ajooni Biotech (AJOONI) reported revenue ₹154 Cr, net profit ₹5 Cr and EPS ₹0.30, with a net profit margin of 2.6% and ROE of 3.4%. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see AJOONI stock price BSE.

11 Years of Data
2025 - 2015

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 2.56% 2025 data
EBITDA Margin 5.13% 2025 data
Operating Margin 3.00% 2025 data
Return on Assets 3.16% 2025 data
Return on Equity 3.41% 2025 data

Balance Sheet Ratios

Current Ratio 31.00 2025 data
Equity Ratio 92.63% 2025 data
Asset Turnover 1.23 2025 data

AJOONI Revenue, Net Profit & EBITDA — Year-on-Year Growth

AJOONI YoY (March 2025 vs Period) — revenue +31.6%, net profit +66.7%, EBITDA +50.0%, expenses +30.6%.

Revenue Growth
+31.6%
Year-over-Year
Net Profit Growth
+66.7%
Year-over-Year
EBITDA Growth
+50.0%
Year-over-Year
Expense Growth
+30.6%
Year-over-Year
Assets Growth
+97.9%
Year-over-Year
Equity Growth
+104.7%
Year-over-Year
Operating Cash Flow Growth
-178.3%
Year-over-Year
Investing Cash Flow Growth
-312.5%
Year-over-Year
Financing Cash Flow Growth
+725.0%
Year-over-Year

AJOONI Income Statement — Revenue, EBITDA & Net Profit

Ajooni Biotech revenue ₹154 Cr, EBITDA ₹9 Cr, net profit ₹5 Cr, EPS ₹0.30 (None) — net profit margin 2.6%. Explore AJOONI value investing to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 154 117 82 75 74 51 40 40 43 29 13 7
Expenses 145 111 78 72 71 49 39 39 42 28 13 7
EBITDA 9 6 4 3 3 2 1 1 1 1 0 0
Operating Profit Margin % 4.00% 3.00% 3.00% 4.00% 4.00% 3.00% 3.00% 2.00% 2.00% 2.00% 2.00% 2.00%
Depreciation 2 1 1 1 1 1 1 0 0 0 0 0
Interest 1 0 1 1 1 1 0 0 0 0 0 0
Profit Before Tax 7 4 3 2 2 1 1 1 1 0 0 0
Tax 2 1 1 1 0 0 0 0 0 0 0 0
Net Profit 5 3 2 1 1 0 0 0 0 0 0 0
Earnings Per Share (₹) 0.30 0.20 0.25 1.94 0.21 0.37 0.41 0.67 0.66 8.34 4.11 3.10

AJOONI Balance Sheet — Assets, Liabilities & Shareholders' Equity

AJOONI total assets ₹95 Cr, total equity ₹88 Cr, total liabilities ₹ Cr (2025) — ROE 3.4%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 95 48 59 29 28 23 18 19 13 2 2
Current Assets 62 32 35 22 21 18 12 11 6 2 1
Fixed Assets 11 10 6 6 5 2 1 1 1 0 0
Capital Work in Progress 0 1 0 0 0 0 0 0 0 0 0
Investments 4 2 4 1 1 3 0 0 0 0 0
Other Assets 80 34 48 22 22 18 17 18 12 2 1
LIABILITIES
Total Liabilities
Current Liabilities 2 2 2 3 2 1 4 2 4 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 88 43 42 16 16 16 12 11 1 1 0
Share Capital 34 18 18 10 10 8 6 6 0 0 0
Reserves & Surplus 54 25 24 6 6 8 6 5 1 0 0

AJOONI Cash Flow Statement — Operating, Investing & Financing

Ajooni Biotech operating cash flow ₹-18 Cr, investing ₹-17 Cr, financing ₹25 Cr, net cash flow ₹-10 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities -18 23 -6 4 1 -4 -5 -3 -3 -1 0
Investing Activities -17 8 -16 -2 -3 1 1 -1 -2 0 0
Financing Activities 25 -4 22 -2 2 3 -1 8 5 1 0
Net Cash Flow -10 27 0 0 0 -1 -5 5 0 0 0